Home›Stock Screener›Johnson Pharmacare

Johnson Pharmacare Share Price Today | Stock Price & Johnson Pharmacare Share Screener

JOHNPHARMA Commercial Services
Live Share Price BSE
₹0.44
▲ 0.00 (0.00%)
2026-11-19 00:00:00

As of November 19, 2026, the live Johnson Pharmacare share price (BSE: JOHNPHARMA) is ₹0.44, unchanged from the previous close, with shares trading between ₹0.43 and ₹0.45 in today's trading session, and a 52-week range of ₹0.37–₹0.63. Track Johnson Pharmacare marketcap in USD to gauge the company's total market size. Use the Johnson Pharmacare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Johnson Pharmacare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹2 and net income of ₹-57, with EBITDA of ₹-55.

Johnson Pharmacare Market Cap ₹24.20 Cr.
JOHNPHARMA P/E Ratio (TTM) -0.40
Johnson Pharmacare P/B Ratio 57.50
EPS (TTM) ₹-1.01
Dividend Yield -
Debt to Equity 0.02
JOHNPHARMA 52 Week High ₹0.63
Johnson Pharmacare 52 Week Low ₹0.37
Operating Margin -
Profit Margin -2850.00%
JOHNPHARMA Revenue (TTM) ₹2.00
EBITDA ₹-55.00
Net Income ₹-57.00
Total Assets ₹22.00
Total Equity -

Johnson Pharmacare Share Price Chart

Track the current stock price of Johnson Pharmacare with an interactive chart. Analyse JOHNPHARMA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Johnson Pharmacare stock quote in one place.

The quote of ₹0.44 sits between the 52-week low of ₹0.37 and the 52-week high of ₹0.63.

Johnson Pharmacare Company Profile - Fundamental Screener

Screen Johnson Pharmacare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JOHNPHARMA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Services sector and the Commercial Services industry, and it trades under ISIN INE560F01022.

Company Details

Classification

Sector Services
Industry Commercial Services
Sub-Sector Commercial Services
Segment E

Identifiers and Leadership

ISIN INE560F01022

Johnson Pharmacare Balance Sheet Screener

Screen JOHNPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹22, down from ₹58 in 2025.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 22 58 60 60 60 60 59 60 60 59
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 21 1 2 2 1 1 1 2 2 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 0 56 57 57 58 58 58 58 58 58
Share Capital 55 55 55 55 55 50 50 50 50 50
Reserves & Surplus -55 1 2 2 3 8 8 8 8 8

Johnson Pharmacare Income Statement Screener - Profit & Revenue Analysis

Screen Johnson Pharmacare income statement and profit fundamentals. Analyze JOHNPHARMA quarterly results. Johnson Pharmacare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹2 and net profit was ₹-57, equal to earnings per unit of ₹-1.00.

In that period expenses were ₹57, interest cost ₹1 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹0 and net profit of ₹-56.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 2 0 0 0 3 3 1 0 1 0 0 0 0
Expenses 57 57 1 0 4 3 1 0 1 0 0 0 0

Operating Costs and Margins

EBITDA -55 -57 -1 0 -1 0 0 0 0 0 0 0 0
Operating Profit % 0.00% 0.00% 0.00% 0.00% -53.00% 4.00% 0.00% 0.00% -1.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 1 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax -57 -56 -1 0 -1 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit -57 -56 -1 0 -1 0 0 0 0 0 0 0 0
EPS -1.00 -1.01 -0.01 0.00 -0.02 0.00 0.00 -0.02 0.00 -0.01 -0.02 -0.03 -0.01

Johnson Pharmacare Cash Flow Screener - Liquidity Fundamentals

Screen JOHNPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities used ₹2.

Over the same period, investing activities provided ₹3 and financing activities used ₹1.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities -2 0 0 5 0 0 -1 -1 11 -11
Investing Activities 3 0 -1 -5 0 1 1 0 -11 11

Financing and Net Cash

Financing Activities -1 0 1 0 0 -1 0 1 0 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 0

Johnson Pharmacare Shareholding Pattern Screener

See Johnson Pharmacare shareholding pattern with promoter, FII, and DII holdings. Check Johnson Pharmacare promoter holding and ownership changes for JOHNPHARMA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 0.00%, foreign institutions 0.00%, domestic institutions 0.00% and the public 85.56%, spread across 117,101 shareholders.

The shareholder count was 117,101 in 2026-Mar, compared with 117,101 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 85.56% 85.56% 85.56% 85.56% 85.56% 85.56% 85.56% 85.56%
Other Holding 14.44% 14.44% 14.44% 14.44% 14.44% 14.44% 14.44% 14.44%
Shareholder Count 117,101 117,101 117,105 117,098 117,101 117,101 116,926 116,901

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Johnson Pharmacare. Johnson Pharmacare dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Johnson Pharmacare.

Johnson Pharmacare Stock Index Membership - Nifty & Sensex

See which indices include Johnson Pharmacare stock. Check JOHNPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Johnson Pharmacare is not part of any tracked indices.
Only major market indices are tracked in our system.

Johnson Pharmacare Market Events Screener - Corporate Actions

Get Johnson Pharmacare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Johnson Pharmacare stock events that may affect JOHNPHARMA share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 13, 2026, with a record date of August 13, 2026.

It is followed by Quarterly Result Announcement dated May 27, 2026 and Quarterly Result Announcement dated February 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-13 2026-08-13 Quarterly Result Announcement NA 2.13%
2026-05-27 2026-05-27 Quarterly Result Announcement NA -1.79%
2026-02-14 2026-02-14 Quarterly Result Announcement NA -3.28%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 1.59%
2025-09-25 2025-09-25 Annual General Meeting NA -1.28%
2025-07-23 2025-07-23 Quarterly Result Announcement NA -2.27%
2025-05-23 2025-05-23 Quarterly Result Announcement NA 5.81%
2025-01-31 2025-01-31 Quarterly Result Announcement NA -1.90%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 3.57%
2024-09-28 2024-09-28 Annual General Meeting NA -1.72%
2022-04-07 2022-04-08 Bonus 1:10 30.97%
2021-08-23 2021-08-23 Change Of Name NA 0.00%

Johnson Pharmacare Competitors Screener - Peer Stocks Comparison

Screen JOHNPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Redington 26,623 17.30 119,347 19.87% 1,284 44.60
Firstsource Solutions 20,028 28.40 9,564 19.86% 674 50.03
International Gemological Institute 18,743 28.50 1,662 52.68% 711 75.27
eClerx Services 14,746 20.40 4,218 22.18% 707 34.67
Central Mine P & D Institute 13,345 20.10 2,398 10.10% 613 45.12
WeWork India Management 9,791 97.30 2,440 20.56% 53 67.90
MMTC 8,087 27.70 181 -31.28% 387 48.10
Nesco 7,441 18.40 1,038 20.00% 413 55.80
Indiabulls 6,808 12.50 881 63.14% 346 42.62
Rentomojo 6,240 92.50 394 44.89% 104 56.97

Johnson Pharmacare Company Announcements - News & Reports Screener

Screen JOHNPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 26, 2026.

The next most recent announcements are dated August 14, 2026 and August 13, 2026.

Date Update Actions
2026-09-26 Closure of Trading Window -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On June 30Th 2026. -
2026-08-13 Submission Of Un-Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter Ended On June 30Th 2026 And Along With Limited Review Report Thereon. -
2026-08-13 Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Thursday 13Th August 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-08-11 Announcement under Regulation 30 (LODR)-Change in Registered Office Address -
2026-08-08 Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited (Standalone) Financial Results For The Quarter Ended On 30Th June 2026. -
2026-07-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-26 Closure of Trading Window -
2026-06-19 Submission Of Audited Financials Results Of Jhonson Pharmacare Ltd. For The Quarter And Year Ended On March 31St 2026 -
2026-06-12 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-06-01 Outcome Of Meeting Of Board Of Directors Held On Wednesday 27Th May 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-05-30 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-28 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-27 Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015. -
2026-05-27 Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter And Financial Year Ended On March 31St 2026. -
2026-05-27 Submission Of Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter And Financial Year Ended On March 31St 2026 Along With Audited Report Thereon -
2026-05-27 Submission Of Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter And Financial Year Ended On March 31St 2026 Along With Audited Report Thereon -
2026-05-27 Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Wednesday 27Th May 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-05-22 Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Audited Financial Results For The Quarter & Year Ended On 31St March 2026. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹0.44, within a 52-week range of ₹0.37 to ₹0.63. The P/E ratio is -0.40 and the P/B ratio is 57.50, with earnings per unit of ₹-1.01. Market capitalisation stands at ₹24.20 Cr. The company operates in the Services sector, in the Commercial Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.